Model Study on Cervical Cancer Screening Strategies and Risk Prediction

CompletedOBSERVATIONAL
Enrollment

1,112,846

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

April 30, 2024

Study Completion Date

June 30, 2024

Conditions
Cervical Cancer ScreeningRisk AssessmentArtificial IntelligenceMachine Learning
Interventions
OTHER

Artificial intelligence model building

Using non-image medical data of cervical lesions and clinical pathology results in different medical institutions, machine learning is adopted to establish multiple multi-modal cervical cancer intelligent screening prediction models. This method was used to analyze the prediction performance of the multi-modal cervical cancer intelligent screening prediction and risk triage model, and to evaluate and optimize the self-learning ability of the established multi-modal cervical cancer intelligent screening prediction model.

Trial Locations (7)

350001

Fujian Maternity and Child Health Hospital, Fuzhou

Unknown

Ningde maternal and child health hospital, Ningde

Gansu Provincial Maternity and Child-care Hospital, Lanzhou

Shunde Women's and Children's Hospital of Guangdong Medical University, Foshan

Shenzhen Maternal and Child Health Hospital, Shenzhen

Guiyang maternal and child health care hospital, Guiyang

Hubei Maternal and Child Health Hospital, Wuhan

All Listed Sponsors
lead

Fujian Maternity and Child Health Hospital

OTHER

NCT06204133 - Model Study on Cervical Cancer Screening Strategies and Risk Prediction | Biotech Hunter | Biotech Hunter